Explore the Category
The deadline for public comment on Government’s controversial medicine pricing regulations has come and gone.
All stakeholders in the healthcare industry have long recognised the need for a transparent pricing system, which could create stability and reduce the cost of pharmaceuticals.
Medical aid scheme premiums rise by nearly twice the rate of inflation. One of the significant cost drivers is the price of imported technology.
Figures released by Medscheme, show that the cost of treating mental illness is increasing significantly.
The strongest deterrent against FSP compliance missteps is or should be: